Cargando…

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

BACKGROUND: Treatment options for many cancers include immune checkpoint inhibitor (ICI) monotherapy and combination therapy with impressive clinical benefit across cancers. We sought to define the comparative cardiac risks of ICI combination and monotherapy. METHODS: We used VigiBase, the World Hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cone, Eugene B., Haeuser, Lorine, Reese, Stephen W., Marchese, Maya, Nguyen, David-Dan, Nabi, Junaid, Chou, Wesley H., Noldus, Joachim, McKay, Rana R., Kilbridge, Kerry Laing, Trinh, Quoc-Dien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624428/ https://www.ncbi.nlm.nih.gov/pubmed/36318537 http://dx.doi.org/10.1371/journal.pone.0272022

Ejemplares similares

Cardiovascular toxicities associated with abiraterone compared to enzalutamide–A pharmacovigilance study
por: Cone, Eugene B., et al.
Publicado: (2021)

Mobile Health App for Prostate Cancer Patients on Androgen Deprivation Therapy: Qualitative Usability Study
por: Nabi, Junaid, et al.
Publicado: (2020)

Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers
por: Cone, Eugene B., et al.
Publicado: (2020)

Recovery from minimally invasive vs. open surgery in kidney cancer patients: Opioid use and workplace absenteeism
por: Krimphove, Marieke J., et al.
Publicado: (2021)

Geographic Distribution of Racial Differences in Prostate Cancer Mortality
por: Fletcher, Sean A., et al.
Publicado: (2020)

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
por: Krimphove, Marieke J., et al.
Publicado: (2019)

Association of Care at Minority-Serving vs Non–Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States
por: Cole, Alexander P., et al.
Publicado: (2019)

RETRACTED: Comparing Long-Term Outcomes Following Radical and Partial Nephrectomy for cT1 Renal Cell Carcinoma in Young and Healthy Individuals
por: Tan, Wei Shen, et al.
Publicado: (2019)

Assessment of Out-of-Pocket Costs for Robotic Cancer Surgery in US Adults
por: Nabi, Junaid, et al.
Publicado: (2020)

A randomized prospective study: assessment of transient ureteral stenting by mono-J insertion after primary URS and stone extraction (FaST 3)
por: Reicherz, Alina, et al.
Publicado: (2021)

Less Is More: Microvascular Thrombophylaxis With Factor-Xa Inhibitor Monotherapy
por: Kotha, Vikas S., et al.
Publicado: (2019)

ASO Author Reflections: How We Convey Empathy, Address Uncertainty, and Share Serious News: Challenges to Remote Surgical Care
por: Sokas, Claire, et al.
Publicado: (2021)

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
por: Reis, Leonardo O., et al.
Publicado: (2019)

Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy
por: Dörrie, Jan
Publicado: (2016)

Understanding Hospital-Level Patterns of Nonoperative Management for Low-risk Thyroid and Kidney Cancer
por: Koelker, Mara, et al.
Publicado: (2022)

National trends in hospital-acquired preventable adverse events after major cancer surgery in the USA
por: Sukumar, Shyam, et al.
Publicado: (2013)

Comparison of Hospital Readmission After Total Hip and Total Knee Arthroplasty vs Spinal Surgery After Implementation of the Hospital Readmissions Reduction Program
por: Ramaswamy, Ashwin, et al.
Publicado: (2019)

Disparities in Outcomes following Admission for Cholangitis
por: McNabb-Baltar, Julia, et al.
Publicado: (2013)

Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies
por: Ouyang, Tao, et al.
Publicado: (2022)

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors
por: Nuzzo, Pier Vitale, et al.
Publicado: (2020)

Association of surgical approach and prolonged opioid prescriptions in patients undergoing major pelvic cancer procedures
por: Krimphove, Marieke J., et al.
Publicado: (2020)

Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
por: Guardascione, Michela, et al.
Publicado: (2020)

Robot-assisted urological surgery: Current status and future perspectives
por: Ghani, Khurshid R., et al.
Publicado: (2012)

The cost impact of disease progression to metastatic castration-sensitive prostate cancer
por: Trinh, Quoc-Dien, et al.
Publicado: (2022)

Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer
por: Zhang, Shijia, et al.
Publicado: (2021)

Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancer
por: Motoo, Iori, et al.
Publicado: (2023)

Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit
por: Tan, Wei Shen, et al.
Publicado: (2021)

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
por: Insull, William, et al.
Publicado: (2010)

Optimal assessment of quality of life for patients with prostate cancer
por: Briggs, Logan G, et al.
Publicado: (2022)

The Use of Chatbots in Oncological Care: A Narrative Review
por: Wang, Alexander, et al.
Publicado: (2023)

Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma
por: Ravi, Praful, et al.
Publicado: (2022)

Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement
por: Oya, Yuko, et al.
Publicado: (2020)

Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non‐small cell lung cancer
por: Chikaishi, Yasuhiro, et al.
Publicado: (2021)

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers
por: Choudhury, Noura J., et al.
Publicado: (2021)

Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail
por: Tritz, Zachariah P, et al.
Publicado: (2021)

Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
por: Byun, Hwa Kyung, et al.
Publicado: (2021)

PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment Research
por: Zhang, Yu, et al.
Publicado: (2021)

Cost-effectiveness of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer in the UK
por: Labban, Muhieddine, et al.
Publicado: (2022)

Changes in anxiety and depression in patients with different income levels through the COVID-19 pandemic
por: Qian, Zhiyu, et al.
Publicado: (2023)

Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
por: Bierman, WFW, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f7c1v7kscsf0mtnf5ii67slurf